BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20851281)

  • 1. Reversible escitalopram-induced hypothyroidism.
    Eker SS; Akkaya C; Ersoy C; Sarandol A; Kirli S
    Gen Hosp Psychiatry; 2010; 32(5):559.e5-7. PubMed ID: 20851281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible paroxetine-induced symptomatic hypothyroidism.
    Takahashi M; Sawayama E; Sawayama T; Miyaoka H
    Pharmacopsychiatry; 2007 Sep; 40(5):201-2. PubMed ID: 17874352
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of escitalopram in patients with severe depression: a pooled analysis.
    Llorca PM; Azorin JM; Despiegel N; Verpillat P
    Int J Clin Pract; 2005 Mar; 59(3):268-75. PubMed ID: 15857321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escitalopram-induced subclinical hypothyroidism. A case report.
    Mazokopakis EE; Karefilakis CM; Starakis IK
    Hormones (Athens); 2012; 11(1):101-3. PubMed ID: 22450350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escitalopram in clinical practice: results of an open-label trial in outpatients with depression in a naturalistic setting in Germany.
    Möller HJ; Langer S; Schmauss M
    Pharmacopsychiatry; 2007 Mar; 40(2):53-7. PubMed ID: 17447173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of desipramine toxicity with citalopram.
    Ashton AK
    J Clin Psychiatry; 2000 Feb; 61(2):144. PubMed ID: 10732663
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute pregabalin reversal of citalopram-induced sexual dysfunction in generalized anxiety disorder.
    Oulis P; Kouzoupis AV; Koulouris G; Masdrakis VG; Kontoangelos K; Matsoukas T; Papadimitriou GN
    J Clin Psychopharmacol; 2008 Jun; 28(3):362-63. PubMed ID: 18480692
    [No Abstract]   [Full Text] [Related]  

  • 8. Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?
    Montgomery SA; Möller HJ
    Int Clin Psychopharmacol; 2009 May; 24(3):111-8. PubMed ID: 19357527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective dose of escitalopram in moderate versus severe DSM-IV major depression.
    Bech P; Andersen HF; Wade A
    Pharmacopsychiatry; 2006 Jul; 39(4):128-34. PubMed ID: 16871468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open-label study of escitalopram (Lexapro) for the treatment of 'Depression of Alzheimer's disease' (dAD).
    Rao V; Spiro JR; Rosenberg PB; Lee HB; Rosenblatt A; Lyketsos CG
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):273-4. PubMed ID: 16477587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder.
    Fantino B; Moore N; Verdoux H; Auray JP
    Int Clin Psychopharmacol; 2007 Mar; 22(2):107-15. PubMed ID: 17293711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Severe forms of depression: the efficacy of escitalopram].
    Spadone C
    Encephale; 2009 Apr; 35(2):152-9. PubMed ID: 19393384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of escitalopram on sleep problems in depressed patients.
    Lader M; Andersen HF; Baekdal T
    Hum Psychopharmacol; 2005 Jul; 20(5):349-54. PubMed ID: 15912558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothyroidism and hyperthyroidism in major depression revisited.
    Fava M; Labbate LA; Abraham ME; Rosenbaum JF
    J Clin Psychiatry; 1995 May; 56(5):186-92. PubMed ID: 7737957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of working but not declarative memory is correlated with HPA normalization during antidepressant treatment.
    Zobel AW; Schulze-Rauschenbach S; von Widdern OC; Metten M; Freymann N; Grasmäder K; Pfeiffer U; Schnell S; Wagner M; Maier W
    J Psychiatr Res; 2004; 38(4):377-83. PubMed ID: 15203289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Depressions resistant to tricyclic antidepressive treatment and hypothyroidism].
    Des Lauriers A; Baruch P; Vindreau C; Jouvent R; Widlöcher D
    Ann Med Interne (Paris); 1987; 138(2):119-22. PubMed ID: 3579093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escitalopram ameliorates prolonged depression with psychotic features induced by interferon therapy for hepatitis C infection: report of 2 cases.
    Kajitani K; Kanba S
    Psychosomatics; 2013; 54(5):506-7. PubMed ID: 23845321
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment research of intermediate severity depression: what is useful for the routine patient?].
    MMW Fortschr Med; 2012 Feb; 154(2):69. PubMed ID: 22352257
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypothyroidism - gait matters.
    Sangle SA; Lohiya RV; Sharma DR; Bote N
    J Postgrad Med; 2012; 58(2):159. PubMed ID: 22718066
    [No Abstract]   [Full Text] [Related]  

  • 20. Interferon-induced depression treated with citalopram.
    Farah A
    J Clin Psychiatry; 2002 Feb; 63(2):166-7. PubMed ID: 11874221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.